Dividend-adjusted total return · S&P 500 uses VOO · Nov 5, 2025 – Nov 6, 2026RXLS&P 500 · VOO
| Returns | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y | MAX |
|---|---|---|---|---|---|---|---|---|
| Total return | −0.4% | +19.6% | +18.9% | +35.9% | +52.8% | +87.9% | +40.1% | +1,712.5% |
| Peer average | +5.2% | −24.9% | −23.8% | −8.3% | −8.7% | +99.4% | +43.8% | — |
| S&P 500 · VOO | +0.3% | −5.0% | −4.6% | +8.7% | +9.8% | +80.8% | +71.8% | — |
Key Statistics
Open all fund facts →- AUM
- $113M
- Expense ratio
- 1.08%
- Distribution yield
- 0.9%
- NAV
- $69.81
- Volume
- 12K
- Avg. volume 30D
- 14K
- High today
- $70.20
- Low today
- $67.01
- Previous close
- $70.03
- 52-week high
- $75.69
- 52-week low
- $42.76
- Our risk indicator
- 5/5
RXL in One Breath
RXL Among An Index ETFs
YTDEnd-of-day Nov 7, 2026 · 85 An index ETFs by YTD
$10,000 in RXL
5Y$10,000 in RXL became
$14,012
In the S&P 500 (VOO)
$17,177
Total return, dividends in · Oct 29, 2021 – Nov 6, 2026 · S&P 500 uses VOO
RXL’s Top Holdings
TodayIQMMProshares Genius Mny Mkt Etf13.3%LLY10.1%JNJ6.1%ABBV4.7%MRK3.4%UNH3.3%TMO2.3%AMGN2.3%GILD1.9%ABT1.8%PFE1.6%ISRG1.5%DHR1.3%VRTX1.3%BMY1.2%MDT1.2%MCK1.2%SYK1.1%CVS1.0%ELVMRNAREGN48 more
IQMMProshares Genius Mny Mkt Etf13.3%LLY10.1%JNJ6.1%ABBV4.7%MRK3.4%UNH3.3%TMO2.3%AMGN2.3%GILD1.9%ABT1.8%PFEISRG58 more
Drug Manufacturers - GeneralAsset Management - BondsMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyOther
ProShares RXL · 70 holdings · tile size = share of the fund · as of Nov 6, 2026
What RXL Holds
TodayDrug Manufacturers - General31.7%
LLY 10.1 · JNJ 6.1 · ABBV 4.7 · MRK 3.4 · AMGN 2.3 · GILD 1.9 · PFE 1.6
Asset Management - Bonds13.3%
IQMM 13.3
Medical - Diagnostics & Research6.8%
TMO 2.3 · DHR 1.3 · IDXX · A · WAT · IQV · MTD
Medical - Healthcare Plans6.7%
UNH 3.3 · CVS · ELV · CI · HUM · CNC
Medical - Devices6.3%
ABT 1.8 · MDT 1.2 · SYK 1.1 · BSX · EW · GEHC · DXCM
Biotechnology3.2%
VRTX 1.3 · MRNA · REGN · INCY · TECH
Other holdings32.0%
ISRG 1.5 · MCK 1.2 · HCA · COR · CAH · BDX · VEEV
ProShares RXL · share of the fund by industry · as of Nov 6, 2026
Proshares’ Share of RXL
Today13.3%
$133 of every $1,000 in RXL is Proshares
Proshares held by RXL
$15.0M
ProShares RXL · each square = $10 of $1,000 · as of Nov 6, 2026
RXL’s Share of An Index ETFs
Today0.1%
of the $120B in 404 An index ETFs
$113M0.1%
$29.1B24.1%
$13.6B11.3%
$77.7B64.5%
An index ETF AUM · Nov 7, 2026
RXL Fee per $100 vs Peers
TodayExpense ratio · An index peers · Nov 7, 2026
Inside RXL
70 holdings · as of Nov 6, 2026RXL
ProShares Ultra Health Care
TodayDrug Manufacturers - General31.7%LLY10.1%JNJ6.1%ABBV4.7%MRK3.4%AMGNGILDPFEBMYAsset Management - Bonds13.3%IQMMProshares Genius MNY MKT ETF13.3%Medical - Diagnostics6.8%TMODHRIDXXAWATIQVILMNLHDGXMedical - Healthcare Plans6.7%UNH3.3%CVSELVCIMedical - Devices6.3%ABTMDTSYKBSXEWVRTXMRNAREGNOther32.0%ISRGMCKHCACORCAHBDX9 more holdings25.9% of the fund
Drug Manufacturers - General31.7%LLY10.1%JNJ6.1%ABBV4.7%MRKAMGNGILD3 moreAsset Management - Bonds13.3%IQMM13.3%Medical - Diagnostics6.8%TMODHRMedical - Healthcare Plans6.7%UNHELVCIMedical - Devices6.3%ABTMDTSYKBSXEWBiotechnology3.2%VRTXMRNAOther32.0%ISRGMCKHCACORCAHBDX12 more holdings26.9% of the fund
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | IQMM | Proshares Genius MNY MKT ETF | 13.25% |
| 2 | LLY | ELI Lilly & | 10.15% |
| 3 | JNJ | Johnson & Johnson | 6.10% |
| 4 | ABBV | Abbvie | 4.73% |
| 5 | MRK | Merck & | 3.37% |
| 6 | UNH | Unitedhealth Group | 3.30% |
| 7 | TMO | Thermo Fisher Scientific | 2.33% |
| 8 | AMGN | Amgen | 2.31% |
| 9 | GILD | Gilead Sciences | 1.93% |
| 10 | ABT | Abbott Laboratories | 1.83% |
Drug Manufacturers - GeneralAsset Management - BondsMedical - DiagnosticsMedical - Healthcare PlansMedical - DevicesBiotechnologyOther
ProShares RXL · current holdings by weight · as of Nov 6, 2026 · each tile is one holding · top 20 = 61.5%
All RXL Holdings
68 holdings · as of Nov 6, 2026RXL
RXL’s Holdings
Today| # | ||||||
|---|---|---|---|---|---|---|
| 1 | —Net Other Assets (Liabilities) | — | 24.59% | $2,458.65 | 27.9M | $27.9M |
| 2 | IQMMProshares Genius MNY MKT ETF | Financial Services | 13.25% | $1,325.24 | 150K | $15.0M |
| 3 | LLYELI Lilly | Healthcare | 10.15% | $1,014.59 | 8,424 | $11.5M |
| 4 | JNJJohnson & Johnson | Healthcare | 6.10% | $609.76 | 25K | $6.9M |
| 5 | ABBVAbbvie | Healthcare | 4.73% | $473.27 | 19K | $5.4M |
| 6 | MRKMerck | Healthcare | 3.37% | $336.84 | 26K | $3.8M |
| 7 | UNHUnitedhealth Group | Healthcare | 3.30% | $330.02 | 9,450 | $3.7M |
| 8 | TMOThermo Fisher Scientific | Healthcare | 2.33% | $232.57 | 3,893 | $2.6M |
| 9 | AMGNAmgen | Healthcare | 2.31% | $231.21 | 5,692 | $2.6M |
| 10 | GILDGilead Sciences | Healthcare | 1.93% | $193.06 | 13K | $2.2M |
| 11 | ABTAbbott Laboratories | Healthcare | 1.83% | $182.64 | 18K | $2.1M |
| 12 | PFEPfizer | Healthcare | 1.56% | $155.96 | 60K | $1.8M |
| 13 | ISRGIntuitive Surgical | Healthcare | 1.54% | $153.77 | 3,719 | $1.7M |
| 14 | DHRDanaher | Healthcare | 1.32% | $131.58 | 6,587 | $1.5M |
| 15 | VRTXVertex Pharmaceuticals | Healthcare | 1.28% | $127.78 | 2,669 | $1.4M |
ProShares RXL · every reported holding · per $10,000 = dollars of each holding in a $10,000 stake · as of Nov 6, 2026
How It Compares
RXL
ProShares Ultra Health Care’s Peers
YTDAn index peers · YTD and past-year returns · as of Nov 8, 2026 · sorted by AUM
Head to Head
Put RXL head to head with QLD →QLD vs RXL
YTDYear to date
RXL wins+30.5 pts
Past year
RXL wins+51.5 pts
Fee
QLD winslower fee
Yield
RXL wins+0.7 pts
AUM
QLD101.3× more
3–1RXL wins
ProShares QLD and ProShares RXL · year-to-date · as of Nov 8, 2026 · AUM not scored
RXL vs VOO
YTDRXL · ProShares Ultra Health Care
+35.9%
VOO · S&P 500
+8.7%
Gap
27.2 pts
ProShares RXL and Vanguard VOO · YTD total return · as of Nov 8, 2026
RXL vs Its Peer Average
YTDRXLAvsBPeer average
1D−0.4%+5.2%
1M+19.6%−24.9%
3M+18.9%−23.8%
YTD+35.9%−8.3%
1Y+52.8%−8.7%
3Y+87.9%+99.4%
5Y+40.1%+43.8%
4–3RXL wins
229 An index peers · each row scaled to its leader
The Details
RXL
Risk
1Y5/5our risk indicator
CalmerBumpier
Volatility · 1Y33.64%
Deepest drop · 1Y−21.3%
Lowest point · 5Y−26.5%
52-week range
$69.78
$42.76−7.8% from the high$75.69
ProShares RXL · past-year price moves · as of Nov 8, 2026
RXL
Fund Facts
Today2007launched Jan 30
Tracks[…]
Exchange · CUSIPAMEX · 74347R735
StructureETF
Leverage2x
Cost on $10,000$108 a year
Go deeper
ProShares RXL · fund facts · as of Nov 8, 2026
RXL
Payouts by Year
13Y$0.13per share, Sep 2026
Distribution yield0.9%
PaidEvery quarter
Latest ex-date · paidSep 23 · Sep 29, 2026
12 payouts added up$1.81 a share
ProShares RXL · distributions by ex-date · 2014–2026
All Fund FactsDocuments · trading · fees · every payout
Prospectus & Documents
Trading & Liquidity
Net asset value$69.81
Premium / discount[…]
Median spread · 30D[…]
Volume today12K
Average volume · 30D14K
Shares outstanding[…]
Options[…]
Fees & Costs
Net expense ratio1.08%
Gross expense ratio[…]
Management fee[…]
Cost on $10,000 a year$108.00
Our risk indicator5/5
Estimated yearly cost excludes trading costs and assumes constant assets.
Distributions
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 23, 2026 | Sep 29, 2026 | $0.13 |
| Jun 24, 2026 | Jun 30, 2026 | $0.18 |
| Mar 25, 2026 | Mar 31, 2026 | $0.14 |
| Dec 24, 2025 | Dec 31, 2025 | $0.18 |
| Sep 24, 2025 | Sep 30, 2025 | $0.20 |
| Jun 25, 2025 | Jul 1, 2025 | $0.22 |
| Mar 26, 2025 | Apr 1, 2025 | $0.13 |
| Dec 23, 2024 | Dec 31, 2024 | $0.15 |
| Sep 25, 2024 | Oct 2, 2024 | $0.13 |
| Jun 26, 2024 | Jul 3, 2024 | $0.17 |
| Mar 20, 2024 | Mar 27, 2024 | $0.0860 |
| Dec 20, 2023 | Dec 28, 2023 | $0.0841 |
Issuer contentFrom ProSharesHear the strategy from the people behind RXL.No issuer videos have been published for this fund.Are you the issuer? Claim this fund →
